Standout Papers

Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Advers... 2015 2026 2018 2022 626
  1. Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes (2015)
    Morganna Freeman-Keller, Young‐Chul Kim et al. Clinical Cancer Research

Immediate Impact

3 by Nobel laureates 8 from Science/Nature 71 standout
Sub-graph 1 of 21

Citing Papers

Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
2024 Standout
A high-fat diet promotes cancer progression by inducing gut microbiota–mediated leucine production and PMN-MDSC differentiation
2024 Standout
1 intermediate paper

Works of Allison Richards being referenced

Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
2016

Author Peers

Author Last Decade Papers Cites
Allison Richards 1047 516 221 17 1.3k
Ilenia Pellicciotta 724 654 312 21 1.2k
Miren Zuazo 967 719 292 27 1.3k
Kristian M. Hargadon 894 717 369 28 1.4k
Christina M. Kochel 935 631 129 15 1.2k
William Waterfield 986 494 244 12 1.1k
Youjin Lee 893 557 186 10 1.3k
Michelle C.R. Yong 964 820 204 18 1.5k
Hubertus Schmitz‐Winnenthal 836 725 273 23 1.4k
Inka Zoernig 818 616 149 24 1.1k
Amandine Alard 834 704 562 13 1.6k

All Works

Loading papers...

Rankless by CCL
2026